SCHEMBL7154065

SCHEMBL7154065

N[C@H]1CC[C@H](Nc2nc3ncnc-3c(NC3CCN(Cc4ccccc4)CC3)[nH]2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.46
HTT P42858 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
NTSR1 P30989 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ACHE P22303 7/20 0.42
MEN1 O00255 3/20 0.41
RAB9A P51151 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
NOD2 Q9HC29 1/20 0.41
MAPK1 P28482 1/20 0.41
ROCK2 O75116 2/20 0.41
ROCK1 Q13464 2/20 0.41
CCR2 P41597 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
NSD2 O96028 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7154060 1.00 HRH3 (0.46) HRH3HTTSMN1; SMN2LMNAMAPT
Hydrochloric Acid SCHEMBL4889879 0.99 HRH3 (0.45) HRH3HTTSMN1; SMN2LMNAMAPT
Hydrochloric Acid SCHEMBL4889868 0.99 HRH3 (0.45) HRH3HTTSMN1; SMN2LMNAMAPT
SCHEMBL4900445 0.84 HRH3 (0.48) HRH3HTTSMN1; SMN2LMNAMAPT
Hydrochloric Acid SCHEMBL4889999 0.82 PI4KA (0.42) ACHEBCHE
Hydrochloric Acid SCHEMBL4889988 0.82 PI4KA (0.42) ACHEBCHE
SCHEMBL7154106 0.81 APP (0.40) SMN1; SMN2KMT2AACHEMEN1BCHE
SCHEMBL7152982 0.79 MAPKAPK2 (0.38) KMT2AACHEMEN1BCHE
SCHEMBL7152990 0.79 MAPKAPK2 (0.38) KMT2AACHEMEN1BCHE
Hydrochloric Acid SCHEMBL4898540 0.79 BTK (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP claimed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO claimed